Search
Showing results for "1"
Research
Prevalence and predictors of vitamin D deficiency in a nationally representative sample of Australian Aboriginal and Torres Strait Islander adultsVitamin D deficiency (serum 25-hydroxyvitamin D (25(OH)D) concentration <50 nmol/l) is recognised as a public health problem globally. The present study details the prevalence and predictors of vitamin D deficiency in a nationally representative sample (n 3250) of Australian Aboriginal and Torres Strait Islander adults aged ≥18 years. We used data from the 2012-2013 Australian Aboriginal and Torres Strait Islander Health Survey (AATSIHS). Serum 25(OH)D concentrations were measured by liquid chromatography-tandem MS.
Explore some of the frequently asked questions that The C3 Study receives.
The Centre includes researchers at The Kids Research Institute Australia’s Diabetes Research Team and the Diabetes Service at the Perth Children’s Hospital.
News & Events
Would you like to test our new exercise app?Our research team have been working with young people with type 1 diabetes to design and develop an app that contains guidelines and advice for what to do when you are being physically active.
News & Events
Helping to relieve diabetes distressThe burden of having T1D is enormous and our researchers are conducting a study trying to understand how we can help relieve diabetes distress.
News & Events
National Community and Consumer Involvement Committee UpdateNational committee members are a really important part of our research projects. Find out what they have been working on.
Strengthening the capacity of Aboriginal children, families and communities
Read about the management staff of the Children's Diabetes Centre, Dr Charles Czank and Nirubasini Paramalingam.
News & Events
Farewell TariniAfter nearly two-and-a-half years in sunny Perth, Dr Tarini Chetty is headed back home to Scotland. Before she departs our shores.
Research
Barriers and Considerations for Diagnosing Rare Diseases in Indigenous PopulationsAdvances in omics and specifically genomic technologies are increasingly transforming rare disease diagnosis. However, the benefits of these advances are disproportionately experienced within and between populations, with Indigenous populations frequently experiencing diagnostic and therapeutic inequities. The International Rare Disease Research Consortium (IRDiRC) multi-stakeholder partnership has been advancing toward the vision of all people living with a rare disease receiving an accurate diagnosis, care, and available therapy within 1 year of coming to medical attention. In order to further progress toward this vision, IRDiRC has created a taskforce to explore the access barriers to diagnosis of rare genetic diseases faced by Indigenous peoples, with a view of developing recommendations to overcome them.